IPF-话题@MedSci

#IPF#

16篇内容 | 1030人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1339910, encodeId=3c031339910c2, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降, objectType=article, longId=727875, objectId=378ce27875c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=378ce27875c7, replyNumber=0, likeNumber=51, createdTime=2022-05-27, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=378ce27875c7, moduleTitle=为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=378ce27875c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339909, encodeId=4fb6133990951, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物, objectType=article, longId=218116, objectId=cba0218116db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba0218116db, replyNumber=0, likeNumber=49, createdTime=2021-10-06, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba0218116db, moduleTitle=Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba0218116db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339908, encodeId=e9ec1339908aa, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Lancet Respirat Med：吡非尼酮或可缓解除了IPF以外的纤维化ILD的病情进展, objectType=article, longId=209630, objectId=b1b2209630f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1b2209630f3, replyNumber=0, likeNumber=47, createdTime=2021-04-08, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1b2209630f3, moduleTitle=Lancet Respirat Med：吡非尼酮或可缓解除了IPF以外的纤维化ILD的病情进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1b2209630f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339907, encodeId=f88e133990e93, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Cell Death Dis：YIPF2通过增强TNFRSF10B质膜再循环促进化疗介导的NSCLC细胞凋亡反应, objectType=article, longId=192991, objectId=47491929915f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47491929915f, replyNumber=0, likeNumber=50, createdTime=2020-04-27, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47491929915f, moduleTitle=Cell Death Dis：YIPF2通过增强TNFRSF10B质膜再循环促进化疗介导的NSCLC细胞凋亡反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47491929915f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339906, encodeId=670913399062c, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Chest：病毒感染与IPF风险, objectType=article, longId=183087, objectId=3c2f18308e95, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c2f18308e95, replyNumber=0, likeNumber=47, createdTime=2019-11-18, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c2f18308e95, moduleTitle=Chest：病毒感染与IPF风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c2f18308e95)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339905, encodeId=bc0513399050d, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=百健放弃开发IPF在研药物, objectType=article, longId=179742, objectId=ba841e974286, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba841e974286, replyNumber=0, likeNumber=44, createdTime=2019-09-21, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba841e974286, moduleTitle=百健放弃开发IPF在研药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba841e974286)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339904, encodeId=6e4f13399049e, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=NEJM：尼达尼布+西地那非对IPF患者症状无显著改善作用, objectType=article, longId=149032, objectId=d833149032b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d833149032b9, replyNumber=0, likeNumber=33, createdTime=2018-09-19, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d833149032b9, moduleTitle=NEJM：尼达尼布+西地那非对IPF患者症状无显著改善作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d833149032b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339903, encodeId=5da213399031f, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=特发性肺纤维化为何难治？IPF患者援助项目启动, objectType=article, longId=137288, objectId=ac0413e2882e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0413e2882e, replyNumber=0, likeNumber=40, createdTime=2018-05-06, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0413e2882e, moduleTitle=特发性肺纤维化为何难治？IPF患者援助项目启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac0413e2882e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339902, encodeId=c7ba1339902f5, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=IPF世界周关注不是癌症的癌症, objectType=article, longId=113799, objectId=e654113e99f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e654113e99f1, replyNumber=0, likeNumber=40, createdTime=2017-09-24, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e654113e99f1, moduleTitle=IPF世界周关注不是癌症的癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e654113e99f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339901, encodeId=188b133990179, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=新的实验数据为尼达尼布治疗IPF的关键作用提供支持, objectType=article, longId=112832, objectId=cff5112832e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cff5112832e2, replyNumber=0, likeNumber=42, createdTime=2017-09-16, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff5112832e2, moduleTitle=新的实验数据为尼达尼布治疗IPF的关键作用提供支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cff5112832e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339900, encodeId=b85d13399006d, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Thromb Haemostasis：IPF作为非心脏手术后MACE的新生物学标志！, objectType=article, longId=109056, objectId=ba7110905639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba7110905639, replyNumber=0, likeNumber=28, createdTime=2017-08-18, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba7110905639, moduleTitle=Thromb Haemostasis：IPF作为非心脏手术后MACE的新生物学标志！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba7110905639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339899, encodeId=037013398996f, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=罗氏 vs 勃林格好戏上演——FDA同时批准2种IPF新药, objectType=article, longId=41456, objectId=7e9e41456e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9e41456e6, replyNumber=0, likeNumber=44, createdTime=2014-10-22, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9e41456e6, moduleTitle=罗氏 vs 勃林格好戏上演——FDA同时批准2种IPF新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9e41456e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339898, encodeId=e20a1339898d0, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=InterMune治疗IPF药物获得FDA突破性药物认证, objectType=article, longId=38154, objectId=33d338154e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d338154e7, replyNumber=0, likeNumber=49, createdTime=2014-07-25, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d338154e7, moduleTitle=InterMune治疗IPF药物获得FDA突破性药物认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33d338154e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339897, encodeId=f31f133989ece, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=Ann Intern Med:安倍生坦不能有效治疗IPF, objectType=article, longId=20610, objectId=c710206107e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c710206107e, replyNumber=0, likeNumber=36, createdTime=2013-06-29, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c710206107e, moduleTitle=Ann Intern Med:安倍生坦不能有效治疗IPF, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c710206107e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339896, encodeId=73051339896f6, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=AIM：沙利度胺可改善特发性肺纤维化（IPF）患者咳嗽症状, objectType=article, longId=10184, objectId=bf4610184e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf4610184e0, replyNumber=0, likeNumber=41, createdTime=2012-10-10, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf4610184e0, moduleTitle=AIM：沙利度胺可改善特发性肺纤维化（IPF）患者咳嗽症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf4610184e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339895, encodeId=92e813398952c, content=<a href='/topic/show?id=1f669990c9' target=_blank style='color:#2F92EE;'>#IPF#</a>, objectTitle=PloS ONE：乌司他丁用于IPF肺癌切除患者安全可行, objectType=article, longId=3650, objectId=f5433650d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5433650d8, replyNumber=0, likeNumber=33, createdTime=2012-01-08, rootId=0, userName=ms705947299214030, userId=64462500151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5433650d8, moduleTitle=PloS ONE：乌司他丁用于IPF肺癌切除患者安全可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5433650d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IPF

2020-05-29

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降

2022-05-27

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物

2021-10-06

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Lancet Respirat Med：吡非尼酮或可缓解除了IPF以外的纤维化ILD的病情进展

2021-04-08

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Cell Death Dis：YIPF2通过增强TNFRSF10B质膜再循环促进化疗介导的NSCLC细胞凋亡反应

2020-04-27

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Chest：病毒感染与IPF风险

2019-11-18

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

百健放弃开发IPF在研药物

2019-09-21

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

NEJM：尼达尼布+西地那非对IPF患者症状无显著改善作用

2018-09-19

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

特发性肺纤维化为何难治？IPF患者援助项目启动

2018-05-06

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

IPF世界周关注不是癌症的癌症

2017-09-24

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

新的实验数据为尼达尼布治疗IPF的关键作用提供支持

2017-09-16

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Thromb Haemostasis：IPF作为非心脏手术后MACE的新生物学标志！

2017-08-18

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

罗氏 vs 勃林格好戏上演——FDA同时批准2种IPF新药

2014-10-22

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

InterMune治疗IPF药物获得FDA突破性药物认证

2014-07-25

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

Ann Intern Med:安倍生坦不能有效治疗IPF

2013-06-29

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

AIM：沙利度胺可改善特发性肺纤维化（IPF）患者咳嗽症状

2012-10-10

ms705947299214030 (审核中...)

前往app查看评论内容

#IPF#

PloS ONE：乌司他丁用于IPF肺癌切除患者安全可行

2012-01-08

科室
- - 订阅+
  - 更多科室
工具
服务